Quantitative changes in cytological molecular markers during primary medical treatment of breast cancer: A pilot study
- 1 January 1999
- journal article
- clinical trial
- Published by Springer Science and Business Media LLC in Breast Cancer Research and Treatment
- Vol. 53 (1), 51-59
- https://doi.org/10.1023/a:1006179511178
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Measurement of S-phase fraction and ploidy in sequential fine-needle aspirates from primary human breast tumours treated with tamoxifenBritish Journal of Cancer, 1994
- The effects of chemotherapy on morphology, cellular proliferation, apoptosis and oncoprotein expression in primary breast carcinomaBritish Journal of Cancer, 1994
- Effect of tamoxifen on Ki67 labelling index in human breast tumours and its relationship to oestrogen and progesterone receptor statusBritish Journal of Cancer, 1993
- DNA flow cytometry and response to preoperative chemotherapy for primary breast cancerEuropean Journal Of Cancer, 1992
- Breast cancer proliferation measured on cytological samples: a study by flow cytometry of S-phase fractions and BrdU incorporationBritish Journal of Cancer, 1991
- Primary Chemotherapy To Avoid Mastectomy in Tumors With Diameters of Three Centimeters or MoreJNCI Journal of the National Cancer Institute, 1990
- Immunocytochemical Analysis of Estrogen Receptors in Human Breast CarcinomasArchives of Surgery, 1990
- Response to endocrine manipulation and oestrogen receptor concentration in large operable primary breast cancerBritish Journal of Cancer, 1989
- Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapyCancer, 1988
- Assessment of response to therapy in advanced breast cancerBritish Journal of Cancer, 1977